Director Clint Hurt Files Intent to Sell Additional $2.29M in Shares Amidst Ongoing Insider Distribution
summarizeSummary
Director Clint Hurt intends to sell an additional $2.29 million in company shares, continuing a trend of significant insider selling that includes previous sales totaling over $6.5 million in recent months.
check_boxKey Events
-
Director Files Intent to Sell
Director Clint Hurt has filed a Form 144, indicating an intent to sell 10,000 shares of PRIMEENERGY RESOURCES CORP, with an approximate market value of $2.29 million.
-
Continuation of Insider Selling
This proposed sale adds to a series of recent dispositions by Mr. Hurt, including approximately $4.21 million in shares reported sold on April 14, 2026, and an additional $2.31 million sold in the past three months as disclosed in this filing.
-
Broader Insider Distribution Trend
The filing occurs within a period of notable insider distribution, including another director, Gifford Fong, reporting an exit from his beneficial ownership on April 22, 2026.
auto_awesomeAnalysis
Director Clint Hurt has filed a Form 144 indicating an intent to sell an additional 10,000 shares of PRIMEENERGY RESOURCES CORP, valued at approximately $2.29 million. This proposed sale follows a pattern of significant insider selling by Mr. Hurt, who previously reported selling approximately $4.21 million worth of shares in a Schedule 13D/A filing on April 14, 2026. Furthermore, the filing itself discloses that Mr. Hurt has already sold 11,976 shares for $2.31 million in the past three months. This continuous distribution by a director, alongside a recent exit by another director (Gifford Fong on April 22, 2026), signals a lack of conviction from key insiders and could exert further downward pressure on the stock.
At the time of this filing, PNRG was trading at $230.00 on NASDAQ in the Energy & Transportation sector, with a market capitalization of approximately $372.1M. The 52-week trading range was $126.40 to $249.50. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.